secwatch.observer — SEC 8-K summary
======================================

Issuer:     HARVARD BIOSCIENCE INC (HBIO)
CIK:        0001123494
Form:       8-K
Filed at:   2026-03-06T23:59:59+00:00
Accession:  0001171843-26-001384
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.07, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Harvard Bioscience shareholders approve 1-for-10 reverse stock split to regain Nasdaq compliance
--------------------------------------------------------------------------------

- Stockholders approved reverse stock split at March 6, 2026 special meeting; 27.0M votes for, 678K against.
- Board set final ratio at 1-for-10; Charter amendment filed with Delaware Secretary of State.
- Effective time 4:30 p.m. ET on March 13, 2026; split-adjusted trading begins March 16, 2026 under same symbol HBIO.
- Outstanding shares reduced from ~44.7M to ~4.47M; authorized shares unchanged at 80M.
- No fractional shares issued; stockholders entitled to cash payment in lieu based on closing price on March 13.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1123494/000117184326001384/0001171843-26-001384-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1123494/000117184326001384/f8k_030526.htm
  HTML page:      https://secwatch.observer/filing/0001171843-26-001384

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer